product
part
book
mani
differ
commerci
avail
immunoassay
system
describ
instrument
rang
size
floorstand
laboratori
analyz
compact
pointofcar
poc
test
devic
first
poc
test
human
chorion
gonadotropin
base
agglutin
slide
santomauro
sciarra
sinc
continu
expans
avail
rang
kasahara
ashihara
price
rasooli
sia
kricka
gervai
et
al
although
convent
poc
test
selfcontain
compar
small
reagent
reaction
vessel
could
easili
seen
without
aid
magnif
howev
last
decad
larg
varieti
microscal
immunoassay
demonstr
within
research
laboratori
consider
number
alreadi
market
place
strong
pipelin
near
marketreadi
devic
microscal
immunoassay
nanoscal
element
true
nanofluid
immunoassay
still
earli
develop
stage
remain
seen
becom
technic
commerci
viabl
number
primari
object
miniatur
l
l
financialreduct
cost
biolog
materi
consum
manufactur
process
l
l
environmentalreduct
biohazard
solid
liquid
wast
packag
l
l
simplificationintegr
immunoassay
step
includ
sampl
prepar
analysi
data
handl
result
present
essenti
poc
singl
use
assay
l
l
mobilityeas
use
field
situat
eg
resourc
poor
set
l
l
scopecap
multipl
simultan
test
mani
differ
analyt
exampl
proteom
studi
l
l
speedfast
reaction
kinet
aris
shorter
diffusion
distanc
take
concept
assay
miniatur
analyz
instrument
may
also
reengin
becom
integr
test
unit
result
fulli
dispos
immunodiagnost
test
microchipbas
analyz
number
potenti
advantag
benefit
compar
convent
macroscal
analyz
tabl
idea
integr
complex
analyt
function
small
compact
devic
base
concept
micro
total
analysi
system
first
postul
manz
cowork
earli
manz
et
al
concept
aim
integr
mani
possibl
process
step
sampl
sampl
pretreat
separ
detect
data
analysi
compact
labonachip
loc
devic
distinguish
devic
immunosensor
abil
incorpor
separ
step
therebi
avoid
typic
sensor
problem
relat
multianalyt
detect
interfer
harrison
et
al
although
later
flow
test
may
regard
form
loc
discuss
elsewher
see
later
flow
immunoassay
microchip
requir
locbas
devic
miniatur
assembl
typic
involv
dimens
nm
mm
usual
chip
twodimension
appear
manufactur
seri
layer
microfluid
microchip
also
call
fluidic
microchip
chip
contain
chamber
interconnect
narrow
channel
along
sampl
reaction
fluid
transfer
differ
assay
stage
perform
differ
locat
chip
intern
volum
depend
crosssect
geometri
particular
structur
usual
nanolit
microlit
rang
bioelectron
chip
interfac
biomolecul
antibodi
antigen
signal
gener
molecul
nonbiolog
materi
result
transfer
modul
signal
biomolecul
devic
amplifi
electron
contain
builtin
electr
compon
combin
fluidic
element
electr
compon
eg
electrod
locat
within
exampl
microchamb
use
manipul
fluid
constitu
thereof
contain
within
chamber
ronkainen
et
al
chip
usual
fabric
electron
board
provid
connect
electr
compon
within
chip
plug
controllermonitor
origin
form
microarray
compris
order
collect
reagent
immobil
surfac
small
planar
piec
silicon
glass
plastic
chip
schena
schena
array
form
spot
stamp
deposit
reagent
situ
synthesi
reagent
surfac
chip
locat
reagent
array
use
identif
altern
beadbas
format
reagent
coupl
micron
size
bead
differ
optic
properti
capabl
individu
identifi
measur
microarray
reagent
includ
complementari
deoxyribonucl
acid
cdna
oligonucleotid
aptam
antibodi
affibodi
antigen
oligopeptid
tissu
section
size
densiti
number
locat
microspot
array
vari
wide
spot
size
often
less
array
hundr
spot
per
squar
centimet
routin
use
microfabr
earli
microfluid
system
mainli
base
etch
glass
silicon
substrat
follow
thermal
bond
yield
enclos
channel
madou
immunoassay
applic
focus
homogen
format
electrophoret
separ
step
last
year
mark
shift
toward
polym
chip
fabric
inject
mold
emboss
follow
lamin
becker
locascio
liu
becker
gaertner
replicationbas
approach
make
lowcost
microfluid
realiti
need
dispos
poc
immunodiagnost
typic
substrat
materi
includ
polystyren
polycarbon
polymethylmethacryl
cyclic
olefin
copolym
nune
et
al
polydimethylsiloxan
pdm
devic
found
widespread
use
academ
domain
manufactur
simpl
cast
process
surfac
function
immunoassay
requir
mcdonald
et
al
sia
whitesid
zhou
et
al
interestingli
inject
mold
thermoplast
cast
pdm
extend
nanoscal
pattern
attia
et
al
perhap
inevit
immunoassay
scientist
engin
alreadi
prove
except
innov
find
drawn
nanotechnolog
sinc
immunoassay
effect
molecular
reaction
immunoassay
appear
lend
miniatur
potenti
advantag
cost
reduct
greater
capac
nanotechnolog
describ
system
oper
atom
molecular
macromolecular
level
dimens
less
nm
although
immunoassay
involv
molecular
interact
qualifi
nanotechnolog
system
must
element
structur
fabric
control
scale
includ
larger
structur
assembl
compon
nanomet
scale
nanoparticl
size
nm
less
compar
microfluid
fill
via
passiv
capillar
actuat
base
applic
eg
pressur
differenti
electr
field
rotat
forc
dynam
alter
surfac
wettabl
drive
fluid
nanoscal
necessit
novel
nanofluid
approach
overcom
domin
surfac
effect
sparreboom
et
al
eijkel
van
den
berg
multitud
nanoscal
analyt
system
alreadi
emerg
immunodiagnost
devic
far
elus
sparreboom
et
al
napoli
et
al
understand
challeng
potenti
advantag
microand
nanoscal
immunoassay
basic
theoret
principl
need
understood
microand
nanoscal
mani
differ
convent
immunoassay
number
fundament
differ
macroscal
microor
nanoscal
analyt
system
describ
number
public
janasek
et
al
gadelhak
kirbi
chang
affect
immunoassay
mainli
term
fluid
flow
number
analyt
molecul
sampl
ie
detect
issu
section
focus
microscal
format
nanoscal
consider
also
introduc
surfac
tension
result
intermolecular
attract
forc
surfac
liquid
strong
water
due
hydrogen
bond
adjac
water
molecul
aqueou
biolog
fluid
blood
urin
sputum
addit
intermolecular
attract
forc
creat
higher
surfac
tension
increas
viscos
even
centimet
scale
surfac
tension
affect
distribut
sampl
reagent
assay
vessel
microtit
plate
well
size
object
decreas
volum
inertia
decreas
power
three
surfac
tension
decreas
linearli
downscal
henc
microand
nanoscal
surfac
tension
domin
forc
control
surfac
properti
becom
crucial
wet
abil
solid
surfac
contact
liquid
wet
phase
degre
wet
wettabl
determin
balanc
adhes
forc
surfac
free
surfac
energi
cohes
forc
within
wet
phase
surfac
tension
wet
phase
tend
spread
solid
surfac
porou
solid
tend
imbib
wet
phase
case
immunoassay
import
channel
along
fluid
pass
high
wettabl
aqueou
solut
wettabl
determin
measur
contact
angl
drop
aqueou
solut
solid
may
plastic
glass
metal
surfac
tension
correct
use
hydrophil
surfac
attract
droplet
number
method
use
increas
wettabl
plastic
use
assay
devic
includ
corona
discharg
plasma
treatment
chemic
surfac
treatment
includ
clean
prime
coat
etch
increas
temperatur
decreas
surfac
tension
viscos
limit
potenti
immunoassay
protein
denatur
higher
temperatur
surfact
may
also
ad
sampl
flow
matrix
enabl
wet
hydrophob
surfac
inject
mold
plastic
howev
surfact
may
interfer
immunoassay
bind
capillari
flow
exploit
surfac
tension
effect
high
surfacetovolum
media
includ
porou
substrat
eg
nitrocellulosebas
later
flow
devic
enclos
microstructur
surfac
eg
microchipbas
immunodiagnost
eijkel
van
den
berg
water
molecul
attract
hydrophil
surfac
insid
media
caus
lead
edg
narrow
tube
water
move
along
even
forc
graviti
capillari
action
occur
adhes
wall
stronger
cohes
forc
water
molecul
attract
water
molecul
respons
surfac
tension
caus
lead
water
molecul
pull
neighbor
water
molecul
along
behind
capillari
forc
exert
contact
perimet
liquid
channel
wall
therefor
scale
favor
miniatur
due
perimet
becom
larger
rel
channel
crosssect
area
upon
downscal
capillari
fill
microchannel
meniscu
proce
squar
root
time
base
linearli
increas
flow
resist
fill
channel
segment
describ
lucaswashburn
equat
howev
slowdown
passiv
fill
constant
crosssect
channel
overcom
tailor
devic
geometri
andor
surfac
hydrophob
effect
yield
programm
passiv
microfluid
circuit
electrokinet
microscal
immunoassay
system
electroosmot
flow
eof
conveni
mean
fluid
actuat
eof
base
format
ion
layer
charg
surfac
instanc
microchannel
glass
silicon
plasmatr
plastic
substrat
sampl
constitu
form
static
mobil
layer
counter
ion
charg
surfac
electr
field
appli
along
channel
mobil
counter
ion
layer
migrat
toward
opposit
charg
electrod
microscal
system
gener
bulk
flow
liquid
channel
eof
conveni
manipul
fluid
around
microchip
via
electr
field
requir
charg
surfac
difficult
obtain
inject
mold
plastic
microfluid
concentr
analyt
sampl
constant
regardless
sampl
size
sampl
size
reduc
number
molecul
sampl
decreas
immunoassay
analyt
typic
micro
nano
picomolar
concentr
rang
tabl
seen
place
fundament
restrict
scale
immunoassay
sampl
size
scale
sampl
time
larger
true
nanotechnolog
compon
yet
sampl
concentr
reason
chanc
one
molecul
analyt
sampl
impact
low
volum
assay
lowconcentr
sampl
differ
qualit
quantit
determin
theoret
perfect
immunoassay
could
develop
detect
effici
ie
detect
everi
molecul
sampl
signaltonois
ratio
greater
qualit
assay
could
design
base
sampl
volum
less
fl
exampl
howev
reduc
error
quantit
immunoassay
number
analyt
molecul
standard
deviat
approxim
equal
squar
root
number
molecul
sampl
size
would
pl
one
way
allevi
problem
sampl
volum
nanoscal
devic
draw
requir
volum
sampl
across
devic
number
molecul
brought
contact
captur
antibodi
antigen
increas
eijkel
time
integr
flowthrough
system
antibodi
antigen
immobil
onto
surfac
allow
analyt
absorb
concentr
one
point
howev
import
rememb
competit
immunometr
immunoassay
volum
sampl
need
defin
either
via
fix
volum
addit
constrain
system
design
notabl
except
rule
ambient
analyt
immunoassay
see
ambient
analyt
immunoassay
benefici
effect
immunoassay
miniatur
reduc
distanc
molecul
need
travel
time
take
molecul
diffus
scale
second
power
diffus
distanc
invers
proport
molecul
intrins
diffus
coeffici
mainli
govern
molecul
size
liquidphas
assay
molecul
move
freeli
solut
unless
sampl
excess
dilut
assay
reagent
volum
directli
affect
chanc
antigen
antibodi
come
contact
assay
methodolog
progress
focu
move
heterogen
solidphas
immunoassay
format
requir
separ
step
solidphas
assay
one
key
reactant
immobil
reduc
speed
assay
progress
reactant
liquid
phase
freeli
move
use
small
volum
associ
shorten
diffus
time
microscal
assay
therefor
increas
reaction
rate
decreas
time
requir
equilibrium
result
overal
reduc
analysi
time
approach
enhanc
kinet
move
sampl
across
detector
period
time
use
electr
field
attract
molecul
bind
surfac
flowthrough
configur
import
minim
diamet
flow
cell
compris
immobil
captur
antibodi
hofmann
et
al
electr
method
attract
biomolecul
sens
surfac
includ
electrotherm
effect
sigurdson
et
al
feldman
et
al
dielectrophoret
approach
yasukawa
et
al
hart
et
al
detail
see
recent
review
wang
ronkainen
et
al
interestingli
lot
consider
need
refin
nanoscal
analysi
system
convent
scale
law
seem
break
nanoscal
addit
detect
issu
molecul
present
repres
detect
janasek
et
al
could
partial
respons
lack
date
meaning
nanoscal
immunoassay
system
howev
point
much
nanotechnolog
research
still
infanc
detect
issu
overcom
system
nanoscal
one
dimens
andor
time
integr
approach
signal
built
time
eijkel
two
commonli
use
immunoassay
format
competit
immunometr
also
refer
noncompetit
see
principl
competit
immunometr
assay
fundament
limit
competit
immunoassay
signal
level
zero
low
concentr
analyt
rel
high
caus
low
signaltonois
ratio
impair
sensit
sinc
microand
nanoscal
immunoassay
produc
low
level
signal
advantag
use
immunometr
format
maxim
signaltonois
ratio
effect
remov
unbound
signalgener
moieti
crucial
heterogen
immunoassay
perform
ie
ultralow
concentr
bound
label
measur
precis
unbound
label
wash
away
activ
wash
step
incorpor
microfluid
immunodiagnost
devic
passiv
system
challeng
achiev
separ
effici
routin
employ
autom
clinic
analyz
see
separ
system
subcategori
heterogen
assay
ambient
analyt
assay
format
offer
two
distinct
advantag
first
uniqu
sampl
dose
requir
captur
antibodi
sampl
analyt
close
vicin
antibodi
zone
secondli
assay
format
involv
small
microspot
antibodi
typic
less
diamet
space
less
apart
lend
manufactur
microscal
immunoassay
array
see
ambient
analyt
immunoassay
homogen
immunoassay
detect
antibodi
analyt
liquid
phase
homogen
immunoassay
format
tend
less
sensit
heterogen
assay
offer
distinct
advantag
requir
separ
step
remov
unbound
label
detect
antibodi
see
homogen
immunoassay
separationbas
system
includ
affinitybas
electrophoret
electrochromatograph
assay
gener
refer
electrokinet
assay
hou
herr
electrokinet
separ
assay
differenti
follow
categori
affin
prepar
affinitybas
bind
occur
separ
ii
preequilibr
affin
assay
affin
reagent
sampl
mix
equilibrium
chipbas
separ
iii
onchip
equilibr
affin
assay
affin
reagent
sampl
mix
dynam
separ
channel
affin
prepar
approach
use
immunoenrich
immunodeplet
breadmor
help
lower
detect
limit
widen
dynam
rang
immunodiagnost
assay
particular
perform
complex
clinic
sampl
mondal
gupta
locbas
microfluid
system
well
suit
onchip
equilibr
affin
assay
multipl
step
integr
onto
singl
chip
parallel
process
ad
option
simultan
determin
four
hormon
blood
saliva
urin
immunoextract
label
electroelut
min
electrophoret
separ
alreadi
demonstr
wellner
kalish
immunoaffin
sampl
prepar
even
allow
analysi
skin
biopsi
sampl
inflamm
marker
electrophoret
separ
marker
bound
fluoresc
label
detect
antibodi
phillip
wellner
electrokinet
separationbas
microfluid
immunodiagnost
system
includ
devic
measur
antiinflamm
drug
plasma
phillip
wellner
four
channel
system
monitor
insulin
islet
secret
dishing
kennedi
devic
simultan
quantif
four
cancer
marker
serum
electrophoret
separ
yang
et
al
yager
cowork
develop
diffusionbas
immunoassay
bound
unbound
detect
antibodi
differenti
diffus
chang
micron
inc
redmond
wa
usa
develop
competit
homogen
immunoassay
tsensor
fabric
glassmylarglass
hybrid
chip
compris
two
fluid
inlet
lead
two
channel
merg
singl
channel
connect
fluid
outlet
kamholz
et
al
hatch
et
al
laminar
flow
condit
two
fluid
stream
antibodi
reagent
sampl
spike
fluoresceinlabel
antigen
flow
sidebysid
mix
diffus
diffus
antigen
parallel
stream
govern
fraction
bind
antibodi
parallel
flow
stream
competit
sampl
antigen
label
antigen
bind
site
antibodi
stream
provid
basi
antigen
quantit
advantag
assay
dilut
whole
blood
assay
without
need
remov
red
cell
assay
phenytoin
whole
blood
dilut
requir
less
detect
nm
phenytoin
hatch
et
al
import
consider
immunoassay
design
target
immunodiagnost
format
compon
ideal
immunodiagnost
devic
poc
illustr
fig
devic
target
poc
cartridgeread
configur
eg
aler
triag
system
fulli
dispos
test
also
emerg
eg
bayer
mainli
target
home
test
lowresourc
set
overview
key
consider
deriv
target
devic
format
provid
tabl
key
constraint
fulli
dispos
devic
difficulti
implement
activ
fluid
actuat
peripher
equip
use
eg
pump
onu
develop
passiv
devic
base
capillar
fill
microfluid
circuit
heterogen
assay
format
may
give
rise
problem
wash
away
unbound
detect
antibodi
passiv
system
excess
sampl
need
use
wash
effect
immunodiagnost
devic
format
standard
calibr
signal
gener
detect
cover
follow
section
requir
antibodi
appropri
specif
normal
scale
immunoassay
howev
increas
need
microscal
immunoassay
antibodi
high
affin
ie
high
valu
k
eq
monoclon
antibodi
offer
highest
potenti
concentr
activ
antibodi
advantag
microor
nanoscal
devic
monoclon
antibodi
lack
high
affin
achiev
polyclon
antibodi
ideal
antibodi
would
monoclon
high
affin
antibodi
possibl
use
phage
display
gener
high
affin
antibodi
typic
k
eq
larg
phage
display
librari
follow
select
modif
amino
acid
sequenc
complementar
determin
region
use
sequenc
gener
new
phage
dna
sequenc
way
monoclon
antibodi
gener
affin
see
antibodi
heterogen
immunoassay
reagent
immobil
bead
within
microfluid
structur
tarn
pamm
increas
surfacetovolum
ratio
captur
antibodi
immobil
also
reduc
analyt
diffus
distanc
enhanc
mass
transport
typic
bead
matric
includ
polystyrenelatex
ohashi
et
al
yuan
et
al
ihara
et
al
glass
tsukagoshi
et
al
magnet
bead
provid
addit
advantag
avoid
need
physic
confin
barrier
bead
held
magnet
forc
releas
demand
switch
magnet
field
pamm
surprisingli
whole
varieti
magnet
beadbas
immunoassay
implement
microfluid
format
hay
et
al
choi
et
al
petku
et
al
mulvaney
et
al
ahn
peyman
et
al
chen
et
al
commonli
howev
intern
surfac
within
microfluid
structur
use
immobil
antigen
antibodi
coat
surfac
immunoreag
immobil
method
includ
physic
adsorpt
self
assembl
monolay
solgel
coval
coupl
common
chemistri
base
dextran
layer
protein
g
biotinstreptavidin
import
differenti
orient
function
group
limit
activ
immobil
antibodi
direct
function
selfassembl
monolay
sam
produc
microchannel
via
microcontact
print
antibodi
foley
et
al
option
locat
antibodi
directli
sens
surfac
surfac
plasmon
reson
spr
surfac
enhanc
raman
scatter
ser
similarli
antibodi
locat
electrod
field
effect
transistor
fet
electrochem
detect
quartz
crystal
microbal
qcm
cantilev
electromechan
detect
see
onchip
detect
method
detail
challeng
standard
calibr
quantit
microscal
immunoassay
much
normal
scale
see
standard
calibr
clinic
analyz
counterpart
prepar
traceabl
intern
standard
use
confirm
accuraci
microchipbas
immunodiagnost
microfabr
techniqu
capabl
produc
ident
assay
channel
well
microchip
calibr
sampl
run
togeth
sampl
concentr
may
estim
direct
refer
calibr
curv
microscal
assay
kinet
faster
allow
assay
progress
equilibrium
shorter
time
assay
reach
equilibrium
forgiv
small
differ
assay
condit
sampl
calibr
also
small
scale
easier
achiev
equilibrium
temperatur
quickli
across
rang
sampl
immunometr
assay
nearlinear
doserespons
curv
may
requir
two
calibr
theori
assay
low
nonspecif
bind
nsb
linear
doserespons
calibr
one
calibr
calibr
oper
clearli
option
cartridgereaderbas
system
adjust
calibr
base
respons
known
concentr
analyt
process
difficult
achiev
dispos
poc
immunodiagnost
factorygener
calibr
curv
may
use
store
electron
test
devic
deterior
accuraci
storag
time
compens
adjust
simpli
provid
limit
valid
shelf
life
matrix
effect
bufferbas
calibr
blood
sampl
may
exagger
microchannel
differ
surfac
tension
effect
reduc
dilut
sampl
introduc
manual
intervent
requir
lessen
number
molecul
sampl
may
impair
assay
sensit
dispos
immunodiagnost
store
buffer
solut
microchip
also
difficult
implement
fluid
evapor
limit
shelf
life
diagnost
test
immunoassay
signal
potenti
weak
low
concentr
analyt
microscal
assay
format
signal
weaker
still
essenti
high
specif
activ
label
use
high
signaltonois
ratio
must
achiev
sourc
nois
must
elimin
detail
discuss
signal
gener
system
immunoassay
provid
separ
chapter
see
signal
gener
system
detect
system
discuss
specif
signal
gener
challeng
solut
microscal
immunoassay
convent
immunodiagnost
test
enzymelink
immunosorb
assay
elisa
format
wide
employ
add
signal
amplif
factor
mean
enzymat
action
commonli
horseradish
peroxidas
hrp
use
conjunct
colorform
tmb
howev
microscal
optic
path
length
absorbancebas
readout
color
chang
limit
within
field
optic
detect
partial
explain
shift
toward
chemiluminescencebas
readout
microscal
also
easier
implement
detector
requir
signal
amplif
also
achiev
via
silverenhanc
nanoparticl
label
nam
et
al
gold
nanoparticl
label
high
diffus
catalyt
enlarg
via
silver
deposit
complex
format
result
silverco
label
detect
high
sensit
use
simpl
camera
scanner
concomit
benefit
poc
diagnost
chin
et
al
vast
major
microscalebas
immunodiagnost
method
howev
still
reli
use
fluoresc
label
commonli
conjug
secondari
detect
antibodi
sandwich
immunoassay
type
test
rather
use
singl
dye
molecul
bead
carri
larg
number
dye
molecul
prefer
yield
stronger
fluoresc
emiss
recent
fluoresc
bead
larg
stoke
shift
excit
emiss
light
becom
avail
facilit
spectral
filtrat
integr
dispos
immunodiagnost
devic
exampl
compris
cascad
dye
polystyren
bead
matrix
gener
stoke
shift
nm
particularli
use
appli
immunodiagnost
chip
integr
headon
fluoresc
detect
ryu
et
al
current
focu
enhanc
signal
gener
microchipbas
immunodiagnost
optic
detect
use
nanotechnologyderiv
probe
myer
lee
azzazi
et
al
quantum
dot
qdot
particular
interest
narrow
tuneabl
emiss
perfectli
suit
multiplex
detect
semiconductor
particl
often
encapsul
polym
microbead
alreadi
appli
simultan
microchipbas
detect
hiv
hbv
hcv
present
problem
remain
qdot
cost
function
stabil
henc
limit
number
poc
diagnost
applic
interest
altern
qdot
signal
gener
rare
earth
metal
contain
ceram
nanospher
act
upconvert
phosphor
yan
et
al
light
absorb
infrar
emit
visibl
spectrum
result
effect
antistok
shift
avoid
background
autofluoresc
bodi
fluid
henc
enhanc
signaltonois
quantit
diagnost
applic
nonopt
detect
approach
increas
surfacetovolum
ratio
encount
microscal
system
exploit
particularli
case
sens
surfac
use
signal
gener
case
electrochem
electromechan
detect
system
next
section
review
exist
optic
nonopt
detect
solut
implement
microscal
microchipbas
analyt
devic
jiang
et
al
constraint
impos
small
volum
short
optic
path
length
myer
lee
addit
need
lowcost
portabl
detect
system
poc
applic
without
compromis
sensit
precis
weigl
et
al
follow
section
outlin
challeng
address
tabl
provid
overview
optic
nonopt
onchip
detect
method
absorb
detect
advers
affect
reduc
optic
path
length
microchip
defin
lambertb
law
number
eleg
solut
develop
increas
optic
path
length
rerout
light
mean
mirror
lens
probe
larger
sampl
volum
describ
review
myer
lee
contrast
lee
cowork
use
deep
mm
detect
chamber
compact
disk
cd
base
system
nm
led
coupl
siphotodiod
detect
hrp
labelinduc
tmb
color
chang
onchip
elisa
hepat
b
lee
et
al
maier
cowork
use
gold
nanoparticl
label
resonanceenhanc
absorpt
elisabas
determin
foodbas
allergen
maier
et
al
detect
limit
ngml
achiev
semiquantit
visual
readout
could
potenti
improv
readout
instrument
absorb
lee
et
al
maier
et
al
fluoresc
herr
et
al
ryu
et
al
ruckstuhl
et
al
jokerst
et
al
meagher
et
al
fluoresc
polar
tachi
et
al
phosphoresc
yan
et
al
chemiluminesc
yacoubgeorg
et
al
yang
et
al
bhattacharyya
klapperich
sista
et
al
tlm
ihara
et
al
ser
mulvaney
et
al
cho
et
al
spr
karlsson
et
al
lee
et
al
felti
et
al
chinowski
et
al
potentiometr
chumbimunitorr
et
al
amperometr
yoo
et
al
nie
et
al
conductometr
capacit
ghafarzadeh
et
al
fet
cui
et
al
stern
et
al
qcm
uludag
tothil
cantilev
waggon
et
al
luchanski
et
al
extens
develop
fluoresc
detect
capabl
microchipbas
immunoassay
earli
work
focus
laserinduc
fluoresc
lif
highenergi
laser
light
focus
small
area
narrow
spectral
emiss
facilit
discrimin
excit
emiss
light
chiem
harrison
jiang
et
al
multichannel
microfluid
immunoassay
simultan
readout
base
scan
fluoresc
detect
system
also
develop
cheng
et
al
recent
integr
portabl
lif
detect
devic
oral
immunodiagnost
demonstr
yield
nanomolar
picomolar
sensit
salivabas
periodont
diseas
marker
herr
et
al
mcdevitt
cowork
reduc
function
convent
benchtop
epifluoresc
microscop
handheld
diagnost
devic
tcell
count
hiv
patient
draw
uniqu
spectral
properti
qdot
jokerst
et
al
compact
integr
lif
immunodiagnost
system
picomolar
sensit
panel
biolog
toxin
develop
sandia
nation
laboratori
meagher
et
al
system
base
integr
electron
miniatur
optic
compris
diod
laser
mirror
lens
filter
photomultipli
tube
pmt
first
step
toward
potenti
fulli
dispos
fluoresc
detect
system
ryu
cowork
develop
integr
immunodiagnost
detect
system
base
inorgan
led
organ
photodiod
nanogram
per
millilit
sensit
report
cardiac
marker
myoglobin
creatin
kinas
mb
ckmb
isoenzym
ryu
et
al
baba
cowork
recent
demonstr
homogen
microchip
theophyllin
assay
fluoresc
polar
detect
tachi
et
al
detect
base
measur
polar
chang
rotat
motion
fluoresc
label
alter
bind
analyt
cite
work
chang
quantifi
via
use
laser
chargecoupl
devic
ccd
camera
fix
rotat
polar
recent
novel
supercrit
angl
fluoresc
saf
immunoassay
concept
implement
dispos
polym
test
tube
valid
detect
low
picomolar
level
ruckstuhl
et
al
saf
occur
surfac
transpar
substrat
use
discrimin
surfac
bind
bulk
effect
henc
circumv
need
labori
elisatyp
wash
step
overcom
limit
fluorescencebas
detect
term
spectral
overlap
excit
emiss
light
longer
live
phosphoresc
could
exploit
timeg
detect
approach
excit
light
puls
emiss
detect
puls
end
howev
approach
requir
sophist
lockin
detect
electron
might
explain
yet
appli
poc
immunodiagnost
assay
separ
approach
base
upconvert
phosphor
see
signal
gener
recent
demonstr
determin
yersinia
pesti
use
compact
portabl
readout
devic
nm
laser
diodebas
excit
pmtbase
detect
emit
light
nm
yan
et
al
chemiluminesc
popular
detect
technolog
choic
immunodiagnost
optic
excit
instrument
requir
particularli
attract
integr
dispos
devic
format
earli
work
model
mous
igg
immunoassay
hrplabel
conjug
detect
capillari
electrophoresi
microchip
use
standard
luminolperoxid
chemistri
mangru
harrison
aluminum
mirror
fabric
onto
back
side
detect
zone
provid
reflect
surfac
enhanc
collect
effici
emit
light
yield
linear
rang
mous
igg
recent
chemiluminesc
detect
extend
capillari
flowthrough
sandwich
immunoassay
biolog
agent
detect
yacoubgeorg
et
al
microperistalt
pump
use
drive
fluid
parallel
microchip
mount
capillari
hrpbase
chemiluminesc
detect
multianodephotomultipli
array
magnet
beadbas
immunoassay
creactiv
protein
crp
serum
demonstr
microchip
integr
pneumat
driven
micropump
microvalv
micromix
chemiluminesc
detect
base
acridium
ester
label
detect
antibodi
offchip
luminometerbas
readout
yield
detect
limit
mgl
crp
mgl
detect
limit
indirect
crp
immunoassay
demonstr
serum
multichannel
inject
mold
cyclic
olefin
chip
use
hrp
luminolbas
chemiluminesc
gener
benchtop
imag
system
readout
bhattacharyya
klapperich
interestingli
onboard
instant
film
modul
also
test
compar
refer
film
could
potenti
exploit
qualit
poc
set
magnet
beadbas
immunoassay
insulin
digit
microfluid
platform
demonstr
pamula
cowork
sista
et
al
hrp
label
react
psatto
substrat
read
pmt
thermal
len
microscop
tlm
base
detect
use
dual
laser
beam
system
measur
phototherm
effect
nonfluoresc
molecul
colloid
gold
label
typic
employ
earli
work
tlm
effect
appli
immunometr
immunoassay
determin
human
secretori
immunoglobulin
carcinoembryon
antigen
cea
sato
et
al
sato
et
al
use
captur
antibodyco
polystyren
bead
confin
glass
channel
ng
ml
detect
limit
cea
achiev
min
incub
recent
kitamori
cowork
appli
highsensit
tlm
detect
microchipbas
opensandwich
elisa
human
osteocalcin
serum
ihara
et
al
use
nm
excit
nm
probe
beam
photodiod
detector
sensit
could
demonstr
osteocalcin
equival
platebas
elisa
result
ser
spectroscopi
molecular
fingerprint
signal
raman
spectra
enhanc
molecul
come
close
proxim
metal
surfac
local
electromagnet
field
enhanc
gener
earli
work
natan
cowork
glasscoat
analytetag
nanoparticl
gan
raman
activ
au
ag
core
use
surfacebound
immunometr
sandwich
format
mulvaney
et
al
laser
use
excit
light
scatter
light
detect
use
ccd
recent
work
lee
cowork
demonstr
labelfre
determin
adenin
polysiliconco
glass
wafer
cho
et
al
electr
field
appli
top
cylindr
wire
electrod
bottom
plate
auelectrod
includ
sersact
region
result
charg
analyt
molecul
accumul
opposit
charg
electrod
detect
region
electrokinet
preconcentr
result
sensit
improv
eight
order
magnitud
read
integr
raman
system
suggest
ser
potenti
demand
lowconcentr
diagnost
applic
spr
allow
direct
labelfre
detect
immun
complex
surfac
detail
see
surfac
plasmon
reson
bind
site
kinet
concentr
analys
notabl
sprbase
system
found
widespread
use
commerci
immunoassay
develop
platform
see
commerci
microfluid
immunodiagnost
describ
applic
spr
microfluidicsbas
immunodiagnost
devic
earli
work
spr
use
conjunct
microfluid
unit
contact
sensor
surfac
measur
kinet
monoclon
antibodyantigen
reaction
real
time
antibodi
antigen
immobil
dextran
matrix
attach
sensor
surfac
bind
event
monitor
spr
karlsson
et
al
last
year
highli
sensit
reliabl
method
low
molecular
weight
analyt
determin
complex
analyt
matric
seen
consider
improv
particularli
term
robust
sens
surfac
compact
instrument
lee
cowork
demonstr
automat
pdm
microchip
micropump
valv
immunoassay
array
twodimension
spr
phase
imag
detect
base
kretschmann
configur
lee
et
al
account
temperatur
sensit
spr
measur
temperatur
control
modul
compris
microheat
temperatur
sensor
also
incorpor
result
preliminari
detect
limit
igg
nm
import
step
toward
poc
applic
davi
cowork
develop
fulli
selfcontain
handheld
spr
devic
power
v
batteri
felti
et
al
demonstr
efficaci
system
ngml
ricin
detect
plastic
cylindr
sensor
cell
via
immobil
antiricin
antibodi
immunoassay
within
min
similarli
yager
cowork
built
compact
spr
imag
spri
instrument
base
diod
light
sourc
imag
detector
integr
digit
signal
processor
passiv
temperatur
control
chinowski
et
al
proof
concept
demonstr
competit
immunoassay
phenytoin
optic
detect
method
versatil
benefit
direct
transfer
convent
clinic
laboratori
assay
format
associ
optic
label
chemistri
requir
hardwar
often
expens
difficult
miniatur
optic
readout
perform
suffer
microscal
format
novel
approach
integr
optic
onchip
detect
overcom
limit
outlin
still
ampl
room
simpler
miniaturiz
detect
technolog
electrochem
detect
provid
viabl
altern
albeit
expens
increas
multianalyt
interfer
remain
problem
electrod
foul
stabil
follow
section
review
current
state
art
electrochem
detect
detail
provid
elsewher
see
immunolog
biosensor
earli
work
phsensit
light
address
potentiometr
sensor
use
monitor
ph
chang
accompani
enzymat
action
bound
ureaselabel
conjug
immunocomplex
captur
membran
brigg
panfili
owicki
et
al
recent
bakker
cowork
demonstr
potentiometr
detect
nanoparticlebas
sandwich
immunoassay
chumbimunitorr
et
al
follow
catalyt
deposit
silver
gold
nanoparticl
label
detect
antibodi
silver
dissolut
potentiometr
detect
use
ag
select
electrod
yield
detect
limit
pmol
igg
sampl
onchip
amperometr
detect
alkalin
phosphatas
label
accomplish
follow
separ
free
antibodi
antibodyantigen
complex
postcolumn
reaction
enzym
label
phosphat
substrat
downstream
amperometr
detect
product
wang
et
al
detect
limit
amol
achiev
model
assay
mous
igg
conduct
channel
glass
microchip
beadbas
microfluid
immunoassay
urinari
hippur
acid
determin
rang
mg
ml
demonstr
pdm
microchip
enzymat
amplifi
amperometr
detect
yoo
et
al
whitesid
cowork
demonstr
chronoamperometr
analysi
glucos
squar
wave
anod
strip
voltammetri
measur
heavi
metal
ion
microfluid
paperbas
electrochem
devic
mped
nie
et
al
simpl
lowcost
devic
compris
two
print
carbon
electrod
work
counter
electrod
print
agagcl
electrod
pseudorefer
electrod
inher
compat
immunoassaybas
analysi
conductometr
immunometr
sandwich
immunoassay
hepat
b
surfac
antigen
hbsag
serum
recent
demonstr
nanogold
label
microcombtyp
electrod
yield
limit
detect
ngml
variant
electrochem
method
capacit
detect
microfluid
immunoassay
complementari
metal
oxid
semiconductor
cmo
base
sensor
also
report
ghafarzadeh
et
al
fet
amin
oxidefunction
borondop
silicon
nanowir
sinw
sourc
drain
use
lieber
cowork
creat
highli
sensit
realtim
immunosensor
cui
et
al
proof
concept
demonstr
monitor
antibiotin
bind
biotinmodifi
sinw
detect
biomark
physiolog
fluid
sampl
far
proven
difficult
due
nsb
biofoul
fahmi
cowork
recent
overcom
problem
develop
microfluid
chip
captur
multipl
marker
blood
sampl
follow
postwash
releas
purifi
buffer
sens
fetbas
silicon
nanoribbon
detector
stern
et
al
efficaci
demonstr
labelless
sandwich
immunoassaybas
detect
two
model
cancer
marker
whole
blood
within
less
min
electromechan
detect
method
base
bind
induc
chang
sens
surfac
measur
electr
mean
qcm
measur
principl
base
surfac
bindinginduc
oscil
chang
quartz
wafer
sandwich
two
electrod
method
inher
labelless
addit
instanc
au
nanoparticl
enhanc
assay
sensit
tothil
cowork
appli
approach
determin
cancer
marker
human
serum
detect
limit
ngml
prostatespecif
antigen
psa
uludag
tothil
main
drawback
poc
immunodiagnost
applic
qcm
sensit
matrix
viscos
necessit
use
onchip
control
cantilev
approach
surfac
stress
gener
antigenantibodi
molecul
recognit
measur
hwang
et
al
waggon
craighead
earli
proof
concept
work
detect
ck
myoglobin
demonstr
arntz
et
al
cho
cowork
shown
detect
urinari
psa
picomolar
concentr
level
cho
et
al
recent
craighead
group
push
sensit
fm
psa
serum
use
nanoparticlebas
mass
label
immunometr
assay
waggon
et
al
silicon
photon
micror
reson
appli
detect
crp
serum
fm
level
dynam
rang
six
order
magnitud
luchanski
et
al
last
year
larg
varieti
immunodiagnost
test
implement
microchip
format
see
tabl
overview
spread
target
analyt
equal
increas
cover
almost
diseas
marker
analyz
clinic
laboratori
particular
interest
howev
cardiac
marker
infecti
diseas
cancer
marker
cardiac
marker
effort
focus
test
myoglobin
ckmb
troponin
crp
btype
natriuret
peptid
bnp
moham
desmulliez
infecti
diseas
test
mainli
cover
tlymphocyt
count
hiv
monitor
dengu
fever
influenza
hepat
c
malaria
tuberculosi
yager
et
al
chin
et
al
work
cancer
marker
often
present
low
concentr
far
includ
psa
tumor
necrosi
factor
liver
cancer
marker
afp
cea
rapid
expans
cover
marker
show
dynam
technolog
advanc
bode
well
futur
microfluidicsbas
immunodiagnost
exist
microfluidicsbas
commerci
system
see
tabl
provid
immunodiagnost
test
poc
facilit
effici
effect
provis
care
see
pointofcar
test
health
care
provid
enabl
decentr
test
effici
use
resourc
patient
benefit
person
medicin
approach
onthespot
diagnosi
earlier
initi
treatment
associ
benefit
diseas
manag
outcom
howev
becom
viabl
enabl
diagnost
tool
widespread
applic
poc
diagnost
test
need
quantit
measur
panel
analyt
portabl
handheld
suffici
low
cost
dispos
huckl
date
overthecount
otc
poc
test
still
later
flow
base
porou
nitrocellulos
matrix
serv
host
reagent
deposit
fluid
flow
see
later
flow
immunoassay
howev
later
flow
system
limit
qualit
semiquantit
analysi
hand
sophist
cartridgereaderbas
system
enabl
quantit
test
analyt
panel
aler
triag
cardiac
marker
panel
see
triag
system
fulli
harvest
power
microfluid
term
abl
integr
larg
number
parallel
serial
analyt
oper
onto
small
lowcost
dispos
microfluid
cartridg
sophist
readout
data
process
capabl
resid
reusabl
reader
howev
access
remot
poc
applic
home
test
still
need
develop
compact
handheld
diagnost
devic
similar
later
flow
test
equival
analyt
capabl
cartridgeread
system
even
full
clinic
laboratori
analyz
section
review
key
microfluid
develop
set
realiz
ambiti
goal
challeng
includ
provis
passiv
flow
control
lowcost
detect
integr
function
immunodiagnost
test
devic
compat
lay
user
employ
lowresourc
set
develop
countri
myoglobin
ckmb
tni
ryu
et
al
crp
bhattacharyya
klapperich
ikami
et
al
bnp
kurita
et
al
cheng
et
al
dengu
fever
lee
et
al
influenza
lien
et
al
hepat
c
einav
et
al
malaria
lafleur
et
al
castilho
et
al
tuberculosi
nagel
et
al
psa
goluch
et
al
panini
et
al
okada
et
al
tradit
laboratorybas
microfluid
system
reli
actuat
fluid
control
typic
posit
pressur
microchip
inlet
use
induc
fill
microfluid
circuit
high
precis
syring
pump
commonli
use
variant
includ
use
integr
micropump
applic
vacuum
microchip
outlet
electroosmot
flow
charg
glass
silicon
surfac
also
exploit
requir
use
highvoltag
power
suppli
microchip
flow
control
approach
requir
support
instrument
therebi
limit
poc
employ
capabl
overcom
current
limit
extens
research
direct
toward
altern
flow
control
mean
west
et
al
arora
et
al
includ
cdbase
system
ducre
et
al
digit
microfluid
jebrail
wheeler
passiv
capillaritybas
system
eijkel
van
den
berg
applic
immunodiagnost
poc
test
gervai
et
al
follow
section
recent
flow
control
approach
introduc
current
technic
statu
review
particular
emphasi
suitabl
poc
immunodiagnost
test
interim
step
laboratorybas
microfluid
system
compact
handheld
poc
devic
centrifug
microfluid
platform
develop
cd
drive
use
control
fluid
flow
microfluid
disk
induc
centrifug
euler
corioli
forc
biodisk
platform
number
fluidic
unit
oper
combin
actuat
liquid
interfac
detect
capabl
yield
semiport
platform
could
potenti
reduc
disk
play
discman
ducre
et
al
date
concept
success
appli
elisabas
immunodiagnost
cardiac
marker
serum
whole
blood
riegger
et
al
shown
compat
absorb
chemiluminesc
riegger
et
al
fluorescencebas
detect
riegger
et
al
group
appli
cdbase
fluid
control
multiplex
immunoassay
honda
et
al
morai
et
al
elisabas
determin
hepat
b
whole
blood
lee
et
al
see
fig
centrifug
approach
result
compact
semiport
devic
offer
robust
liquid
handl
unlik
passiv
capillari
fill
system
constrain
viscos
surfac
tension
effect
howev
current
drawback
includ
cost
reliabl
difficulti
achiev
highsensit
readout
digit
microfluid
sampl
manipul
discret
droplet
insulatorcov
electrod
array
abdelgawad
wheeler
jebrail
wheeler
seri
electr
potenti
appli
electrod
result
charg
accumul
surfac
dynam
alter
wettabl
exploit
dispens
move
merg
mix
split
droplet
often
suspend
immisc
oil
prevent
evapor
crosscontamin
limit
nsb
channel
surfac
open
onepl
configur
use
droplet
manipul
singl
substrat
hous
drive
ground
electrod
poc
immunodiagnost
applic
howev
enclos
twoplat
system
commonli
employ
facilit
devic
handl
limit
fluid
evapor
compat
digit
microfluid
physiolog
fluid
includ
whole
blood
first
demonstr
srinivasan
srinivasan
et
al
immunodiagnost
applic
recent
emerg
pamula
group
develop
dropletbas
magnet
bead
immunoassay
insulin
interleukin
sista
et
al
see
fig
work
sampl
digit
mix
drop
magnet
bead
conjug
captur
antibodi
detect
antibodi
block
protein
form
complex
held
magnet
wash
resuspend
follow
alkalin
phosphatasebas
chemiluminesc
detect
digit
microfluid
platform
appli
determin
troponin
whole
blood
within
min
sista
et
al
owe
advanc
liquid
handl
capabl
system
pcr
could
perform
system
also
demonstr
independ
group
chang
et
al
main
advantag
digit
microfluid
includ
abil
use
modular
scalabl
print
circuit
board
instead
complex
channel
network
compat
solid
instanc
requir
wholeblood
test
flexibl
term
sampl
volum
overal
yield
sophist
liquid
handl
solut
portabl
econom
platform
compat
poc
immunodiagnost
howev
digit
microfluid
still
infanc
problem
persist
nsb
foul
insul
electrod
surfac
autonom
passiv
microchip
flow
control
system
develop
delamarch
cowork
ibm
zimmermann
et
al
base
silicon
capillari
system
css
fill
predominantli
capillari
forc
integr
microfluid
system
compris
fill
port
microchannel
passiv
capillari
pump
outlet
capillari
pump
outlet
compris
branch
channel
increas
surfac
area
promot
fluid
evapor
assist
capillaritybas
fill
interact
flow
control
afford
control
evapor
rate
peltier
elementbas
cool
biofunction
immunoassay
perform
separ
pdm
substrat
attach
cs
group
alreadi
demonstr
detect
cytokin
picomolar
sensit
submicrolit
volum
cesarotad
et
al
earli
work
base
serial
manual
pipet
analyt
detect
antibodi
inlet
port
group
subsequ
focus
implement
autonom
onestep
immunodiagnost
format
process
detect
ngml
crp
serum
demonstr
within
min
passiv
devic
compris
sampl
collector
delay
valv
flow
resistor
reaction
chamber
css
gervai
delamarch
zimmermann
et
al
versatil
sixchannel
onestep
immunoassay
platform
recent
develop
allow
adjust
optim
sampl
flow
rate
sampl
volum
detect
antibodi
concentr
gervai
et
al
independ
shown
group
pump
system
parsa
et
al
sampl
flow
rate
concentr
distribut
detect
antibodi
critic
import
achiev
adequ
sensit
onchip
immunoassay
passiv
cs
platform
reagent
releas
thu
optim
via
control
reagent
integr
enabl
programm
reagent
pickup
onestep
immunodiagnost
chip
hitzbleck
et
al
passiv
onestep
cs
system
combin
excel
perform
flexibl
simplic
use
potenti
low
cost
current
requir
humidifi
chamber
ensur
stabl
flow
rate
limit
poc
applic
current
concert
effort
extend
immunodiagnost
capabl
resourcepoor
set
develop
world
yager
et
al
chin
et
al
follow
assur
criteria
ideal
diagnost
test
afford
sensit
specif
userfriendli
robust
equipmentfre
deliv
need
stipul
world
health
organ
microfluid
enabl
technolog
describ
expect
play
import
role
fulfil
promis
requir
lowresourc
set
deploy
immunodiagnost
test
partial
address
recent
research
shift
away
convent
labonachip
loc
approach
labonapap
system
zhao
van
den
berg
outlin
microchipbas
microfluid
offer
varieti
sophist
solut
poc
immunodiagnost
necessarili
low
cost
without
ancillari
equip
hand
later
flowbas
devic
easi
use
low
cost
standalon
lack
precis
quantif
capabl
labonpap
approach
aim
overcom
perform
limit
later
flow
system
pattern
paper
form
de
facto
microfluid
channel
lowcost
dispos
medium
pattern
plasmatr
paper
first
shown
whitesid
group
proof
concept
demonstr
simultan
colorchangebas
detect
glucos
protein
urin
martinez
et
al
photolithograph
pattern
approach
sinc
refin
rapid
prototyp
method
compat
print
mask
martinez
et
al
enhanc
function
demonstr
vertic
stack
paper
layer
enabl
sampl
distribut
array
reagent
spot
multianalyt
assay
martinez
et
al
programm
system
enabl
applicationspecif
reconfigur
martinez
et
al
system
still
requir
serial
manual
applic
reagent
yager
group
develop
paperbas
system
autom
multireag
deliveri
base
dissolv
trehalos
barrier
fu
et
al
importantli
context
discuss
paper
plate
recent
demonstr
elisabas
hiv
detect
serum
cheng
et
al
work
human
antibodi
captur
immobil
antigen
secondari
goat
antihuman
igg
alkalin
phosphatas
label
introduc
colorimetr
detect
desktop
scanner
addit
reflectancebas
colorimetr
detect
techniqu
use
includ
absorb
fluorescencebas
carrilho
et
al
electrochem
dungchai
et
al
detect
implement
paperbas
system
martinez
et
al
interestingli
earli
effort
alreadi
made
integr
flexibl
electron
base
array
led
light
detector
transistor
paperbas
microfluid
driven
us
consortium
compris
diagnost
univers
illinoi
urbanachampaign
electron
startup
technolog
advanc
combin
complement
addit
addon
specif
address
use
microfluid
immunodiagnost
resourcepoor
set
develop
world
instanc
linder
cowork
develop
method
store
seri
liquid
reagent
plug
convent
polyethylen
tube
need
elisabas
test
linder
et
al
run
assay
tube
simpli
attach
microchip
inlet
vacuum
appli
outlet
draw
reagent
plug
onebyon
appli
approach
pdm
microchip
attach
polystyren
substrat
hiv
diagnosi
serum
demonstr
within
min
nanomolar
sensit
fluoresc
microscopebas
detect
reagent
stabl
room
temperatur
storag
transport
effort
underway
prove
efficaci
approach
field
trial
develop
world
chin
et
al
dri
reagent
storag
format
detect
captur
antibodi
flowthrough
immunoassay
system
develop
yager
cowork
use
develop
world
steven
et
al
dri
reagent
pad
polyest
detect
antibodi
nitrocellulos
captur
antibodi
prepar
offchip
insert
assembl
assay
card
compris
multipl
layer
mylar
pmma
use
extern
syring
pump
drive
fluid
robust
malaria
assay
serum
demonstr
min
subnanomolar
sensit
flatb
scanner
clinic
laboratori
whole
blood
routin
centrifug
yield
plasma
downstream
analysi
microfluid
system
varieti
differ
blood
filtrat
approach
develop
see
review
jiang
et
al
address
specif
need
lowresourc
set
use
manual
eggbeat
devic
wholeblood
separ
explor
wong
et
al
wholeblood
sampl
load
polyethylen
tube
spun
manual
eggbeat
yield
plasma
yield
approxim
plasma
whole
blood
min
suitabl
lowtech
sampl
pretreat
method
demonstr
cholesterol
assay
paperbas
microfluid
would
principl
equal
applic
immunoassay
wholeblood
compat
selfpow
integr
microfluid
blood
analysi
system
simba
demonstr
recent
dimov
et
al
see
fig
interestingli
passiv
onestep
system
sedimentationbas
blood
filtrat
requir
manual
sampl
prepar
extern
equip
fluid
control
instead
reli
degasdriven
passiv
fill
evacu
pdm
chip
ie
store
desicc
vacuum
pouch
use
whole
blood
basic
assay
label
biotin
bind
immobil
avidin
demonstr
low
picomolar
sensit
fluoresc
scannerbas
readout
make
import
transit
readout
compat
lowresourc
set
whitesid
cowork
explor
telemedicin
approach
base
use
wide
avail
camera
phone
martinez
et
al
camera
phone
use
digit
output
colorimetr
onchip
assay
transfer
digit
inform
offsit
analysi
train
medic
profession
approach
suitabl
remot
set
technic
difficulti
remain
vari
imag
intens
depend
camera
phone
ambient
condit
hope
progress
overcom
technic
challeng
bring
full
power
microfluidicsbas
immunodiagnost
poc
includ
resourcepoor
set
develop
world
key
success
factor
poc
devic
immunoassaybas
diagnost
product
gener
describ
elsewher
handbook
later
flow
otc
pregnanc
test
commerci
success
microfluidicsbas
immunodiagnost
product
limit
commerci
applic
see
tabl
scarciti
microfluidicsbas
product
partial
explain
difficulti
achiev
requir
immunoassay
perform
term
accuraci
precis
complex
yet
lowcost
microchip
format
would
gain
market
regulatori
accept
term
regulatori
pathway
microfluidicsbas
immunodiagnost
govern
regul
tradit
immunoassaybas
test
ad
consider
us
poc
applic
prefer
achiev
clinic
laboratori
improv
amend
clia
waiv
statu
demonstr
test
simpl
perform
nonexpert
user
low
risk
error
requir
high
level
precis
robust
configur
failsaf
user
interfac
place
great
demand
design
develop
process
commerci
system
sever
system
develop
regulatori
clearanc
market
accept
thu
far
slower
might
expect
one
success
commerci
microfluidicsbas
diagnost
devic
abbott
handheld
istat
system
provid
realtim
laboratori
qualiti
result
base
electrochem
detect
silicon
chip
wide
use
test
cartridg
provid
eight
metabol
test
includ
ioniz
calcium
hematocrit
drop
whole
blood
within
min
k
clear
cartridg
hematolog
blood
gase
coagul
immunoassaybas
cardiac
marker
determin
also
avail
clia
waiv
bayer
handheld
immunodiagnost
devic
homebas
test
import
longterm
marker
diabet
manag
cliawaiv
devic
compris
microfluid
later
flow
compon
onboard
fluorescencebas
detect
establish
cartridgeread
system
aler
triag
system
provid
cardiac
marker
panel
myoglobin
ckmb
troponin
tni
separ
test
ddimer
bnp
whole
blood
load
onto
passiv
cartridg
drawn
channel
capillar
use
fluorescencebas
readout
quantit
result
obtain
within
min
system
also
qualit
drug
screen
urin
sampl
see
triag
cartridgeread
system
base
labelfre
spr
k
clear
system
intend
use
develop
platform
custom
assay
implement
use
dispos
multichannel
microfluid
syring
pumpbas
actuat
micron
k
clear
aborhcard
provid
simultan
qualit
determin
individu
abo
blood
group
rh
factor
statu
singleus
dispos
credit
cardsiz
devic
yield
visual
read
result
within
minut
fingerstick
whole
blood
interestingli
passiv
microfluidicsdriven
technolog
recent
acquir
soni
quest
diversifi
medic
health
care
domain
wako
diagnost
k
clear
immunoanalyz
liver
cancer
risk
marker
dcp
base
sophist
microfluid
electrophoret
techniqu
immunochem
detect
cartridgeread
system
analyz
six
marker
parallel
yield
first
result
less
min
aler
recent
launch
next
gener
cemark
cardiac
test
triag
platform
includ
cartridg
singleanalyt
improv
sensit
tni
twoanalyt
panel
new
tni
bnp
threeanalyt
panel
new
tni
bnp
ckmb
enhanc
tni
sensit
test
enabl
measur
percentil
allow
earlier
detect
ami
improv
outcom
e
set
claro
diagnost
recent
ce
mark
cartridgereaderbas
psa
test
base
dispos
credit
cardsiz
passiv
microfluid
small
footprint
analyz
highsensit
detect
ag
label
yield
quantit
result
within
minut
fingerstick
sampl
whole
blood
see
fig
apart
diagnost
test
alreadi
market
place
exist
promis
pipelin
developmentstag
immunodiagnost
devic
particular
trend
away
convent
cartridgeread
configur
fulli
integr
dispos
system
remov
need
separ
instrument
reduc
user
complex
mycrolab
mycro
check
system
base
dispos
mycro
card
compris
advanc
microfluid
electron
display
screen
molecular
vision
platform
combin
semiconductorbas
light
sourc
ole
detector
opv
inject
mold
passiv
microfluid
creat
potenti
lowcost
fulli
dispos
immunodiagnost
poc
test
use
bioanalyt
microarray
first
report
feinberg
microlit
sampl
thyroglobulin
antigen
spot
onto
surfac
thin
film
agar
impregn
serum
patient
thyroid
autoimmun
diseas
immunoprecipit
observ
indic
interact
thyroglobulin
antibodi
patient
serum
techniqu
refin
use
cellulos
acet
strip
feinberg
wheeler
decad
later
develop
concept
ekin
cowork
ekin
et
al
chu
led
deriv
ambient
analyt
theori
demonstr
highsensit
multispot
multianalyt
immunoassay
base
principl
miniatur
lead
increas
detect
sensit
first
authent
antibodi
microarray
show
potenti
miniatur
multiplex
immunoassay
major
impact
clinic
diagnost
howev
field
genom
signific
advanc
first
made
technolog
microarray
high
precis
liquid
handl
robot
optic
scanner
becam
avail
complet
human
genom
sequenc
led
develop
dna
microarray
high
throughput
reliabl
process
mrna
express
profil
singlenucleotid
polymorph
analysi
term
biochemistri
diagnost
util
recogn
though
chang
mrna
level
necessarili
proport
chang
protein
level
differ
rate
protein
translat
degrad
addit
nucleotid
test
reveal
noth
regard
posttransl
modif
may
essenti
protein
function
one
gene
encod
number
differ
protein
sinc
protein
mrna
control
cellular
activ
becom
import
identifi
protein
much
technolog
deriv
earlier
genom
microarray
place
major
increas
effort
appli
field
protein
microarray
last
decad
size
task
proteom
research
consider
number
human
protein
judg
order
magnitud
greater
proteincod
gene
possibl
mani
protein
wwwensemblorg
microarray
abil
detect
hundr
thousand
differ
protein
singl
experi
provid
tool
address
problem
wide
use
varieti
applic
includ
drug
develop
classif
biomark
discoveri
patient
profil
therapi
monitor
diagnost
test
sinc
lowabund
protein
often
confer
signific
inform
clear
need
highli
sensit
specif
access
highthroughput
test
platform
protein
detect
quantit
differenti
profil
health
diseas
figur
claro
immunoassay
cartridg
simultan
test
diseas
marker
whole
blood
within
min
current
use
psa
determin
also
test
hiv
syphili
determin
see
chin
et
al
separ
portabl
reader
use
vacuumbas
fluid
actuat
optic
readout
color
version
figur
may
view
wwwimmunoassayhandbookcom
reproduc
permiss
claro
diagnost
basic
concept
array
use
immobil
captur
molecul
defin
locat
either
spatial
posit
optic
identif
bind
specif
singl
analyt
presenc
differ
captur
molecul
allow
simultan
assay
multipl
analyt
complex
mixtur
last
decad
varieti
differ
format
devis
extens
review
scientif
literatur
hall
et
al
simpson
pollard
et
al
hartmann
et
al
yu
et
al
array
typic
classifi
two
type
forwardphas
protein
microarray
fppm
subdivid
analyt
antibodi
array
function
protein
array
reversephas
protein
microarray
rppm
see
fig
one
form
analyt
antibodi
microarray
function
miniatur
version
classic
immunometr
assay
use
librari
antibodi
array
onto
eg
glass
microscop
slide
probe
sampl
solut
captur
protein
subsequ
detect
use
second
label
antibodi
direct
differ
determin
protein
standard
detect
method
includ
fluoresc
chemiluminesc
colorimetri
microarray
typic
use
profil
complex
mixtur
protein
measur
bind
affin
specif
protein
express
level
within
singl
sampl
antibodi
microarray
common
form
analyt
microarray
berton
snyder
techniqu
effect
wellcharacter
protein
good
qualiti
antibodi
avail
often
case
avoid
need
match
pair
antibodi
protein
interest
altern
format
simpli
label
protein
sampl
eg
fluoresc
tag
incub
captur
antibodi
approach
advantag
allow
direct
comparison
two
sampl
eg
srivastava
et
al
one
drawback
method
often
difficult
label
lowabund
protein
high
effici
also
suffer
reduc
specif
use
singl
antibodi
crossreact
may
problem
function
protein
microarray
differ
analyt
microarray
prepar
individu
fulllength
function
protein
protein
domain
use
investig
wider
proteinbind
event
entir
proteom
differ
form
protein
interact
studi
includ
proteinprotein
proteindna
proteinrna
proteinphospholipid
proteinsmal
molecul
hu
et
al
tao
et
al
reversephas
indirect
microarray
sampl
contain
complex
mixtur
protein
immobil
array
probe
specif
label
antibodi
techniqu
develop
overcom
problem
need
two
high
affin
specif
antibodi
protein
studi
paweletz
et
al
complex
sampl
protein
tissu
cell
lysat
biolog
fluid
print
slide
slide
probe
differ
antibodi
within
slide
mani
differ
patient
sampl
serial
dilut
manner
techniqu
highli
suit
screen
larg
cohort
subject
clinic
investig
nucleic
acid
array
materi
common
chemistri
gener
method
use
immobil
regardless
specif
sequenc
case
protein
natur
surfac
slide
method
immobil
profound
effect
protein
conform
function
stabil
henc
mani
differ
techniqu
tri
order
maxim
bind
capac
maintain
conform
function
equip
develop
dna
array
adapt
protein
microarray
select
microscop
slide
support
follow
readi
avail
robot
printer
laser
scanner
use
glass
microscop
slide
support
substrat
mani
differ
surfac
use
includ
polyvinyliden
fluorid
et
al
lueck
et
al
nitrocellulos
polystyren
holt
et
al
agaros
afanassiev
et
al
pdm
zhu
et
al
aldehydeactiv
plain
glass
macbeath
schreiber
method
other
use
coat
polyllysin
coval
attach
glass
surfac
silan
epoxi
deriv
gener
random
orient
protein
slide
surfac
case
advers
affect
protein
affin
tag
avoid
problem
provid
stabl
linkag
reproduc
orient
exampl
includ
use
tag
nickel
surfac
zhu
et
al
ntermin
gst
tag
maltosebind
protein
earlier
way
form
protein
array
includ
adsorpt
onto
ssam
noctyldecyltrimethoxysilan
silicon
dioxid
surfac
previous
pattern
uv
photolithographi
array
micrometers
featur
mooney
et
al
selfassembl
via
hybrid
rnaprotein
fusion
array
surfacebound
dna
captur
probe
weng
et
al
spot
onto
glass
schweitzer
et
al
goldcoat
silicon
silzel
et
al
plastic
surfac
eg
polystyren
jone
et
al
electrospray
deposit
onto
alumin
plastic
avseenko
et
al
immobil
within
array
small
eg
polyacrylamid
gel
pad
glass
surfac
arenkov
et
al
spot
protein
antibodi
two
type
robot
microarray
printer
use
contact
noncontact
contact
printer
use
metal
pin
deposit
nanolit
quantiti
protein
antibodi
solut
directli
contact
slide
pin
dimens
determin
volum
appli
spot
solid
pin
requir
replenish
fluid
applic
use
altern
quill
pin
intern
reservoir
fill
capillari
action
allow
multipl
applic
singl
fill
deposit
volum
depend
contact
time
noncontact
printer
releas
discret
amount
fluid
convent
inkjet
piezoelectr
puls
electrospray
deposit
latter
printer
give
precis
fluid
deliveri
henc
improv
spottospot
variat
although
normal
requir
larger
sampl
volum
sometim
misplac
spot
hartmann
et
al
mani
commerci
organ
suppli
prefabr
custom
array
autom
equip
print
array
perform
test
optic
measur
exampl
includ
aushon
biosystem
wwwaushon
com
arrayit
corpor
wwwarrayitcom
affymetrix
wwwaffymetrixcom
invitrogen
life
scienc
www
invitrogencom
gesim
wwwgesimd
arrayjet
arrayjetcouk
raybiotech
wwwraybiotechcom
r
system
wwwrndsystemscom
gentel
bioscienc
wwwgentelbiocom
addit
sourc
found
wwwbiochipnetcom
one
signific
problem
associ
protein
antibodi
microarray
concern
stabil
protein
gener
antibodi
particular
wide
differ
stabil
microarray
hundr
thousand
deposit
protein
highli
vulner
degrad
protein
individu
uncontrol
basi
contrast
nucleic
acidbas
array
extrem
stabl
take
advantag
taussig
gener
protein
situ
array
pisa
protein
express
directli
dna
becom
attach
array
surfac
made
recognit
tag
sequenc
bind
histidinetag
nascent
protein
nickelco
surfac
slide
improv
made
transcript
translat
immobil
dna
templat
rather
solut
use
pisa
nucleic
acid
programm
protein
array
use
biotinyl
cdna
plasmid
encod
protein
gst
fusion
print
onto
avidinco
slide
togeth
antigst
antibodi
protein
captur
ramachandran
et
al
express
protein
thu
becom
immobil
layout
cdna
anoth
advanc
devis
cowork
et
al
protein
express
perform
membran
held
two
glass
slide
one
array
dna
carri
reagent
captur
translat
protein
tag
protein
express
parallel
migrat
second
slide
immobil
form
protein
array
mirror
imag
dna
array
approach
advantag
result
array
free
dna
use
repeatedli
gener
copi
array
least
repeat
report
avail
specif
antibodi
human
protein
would
theori
allow
profil
entir
human
proteom
number
initi
recent
year
aim
provid
set
character
harmon
binder
import
scope
work
beyond
capabl
singl
organ
even
countri
proteomebind
wwwproteomebindersorg
stoevesandt
taussig
followup
studi
affinityproteom
integr
coordin
effort
number
european
initi
includ
antibodi
factori
germani
wwwantibodyfactoryorg
within
human
proteom
organ
wwwhupoorg
antibodi
resourc
databas
wwwantibodypediaorg
aim
produc
comprehens
catalog
valid
antibodi
human
protein
similarli
us
nation
cancer
institut
set
clinic
proteom
reagent
resourc
develop
monoclon
antibodi
cancer
marker
particularli
low
abund
marker
wwwproteomicscancergov
program
ambiti
technic
feasibl
offer
signific
scientif
econom
reward
detect
method
employ
protein
microarray
analog
use
convent
immunoassay
microarraybas
enzym
immunoassay
enzymelabel
conjug
detect
use
colorimetr
avseenko
et
al
fluorometr
hiller
et
al
chemiluminesc
signal
detect
system
huang
et
al
fluoresc
label
dye
popular
due
common
avail
reagent
microarray
laser
scanner
first
found
use
cdna
oligonucleotid
assay
becom
convent
techniqu
directli
compar
sampl
use
dye
illustr
studi
srivastava
et
al
compar
proteom
signatur
pool
normal
cystic
fibrosi
sera
see
fig
semiconductor
qdot
label
offer
higher
quantum
yield
resist
photobleach
wide
stoke
shift
also
appli
protein
microarray
gave
improv
signal
nois
ratio
compar
convent
fluoresc
label
zajac
et
al
magnet
nanotag
also
propos
altern
fluoresc
label
multiplex
protein
array
claim
analyt
sensit
extend
low
femtomolar
concentr
osterfeld
et
al
increas
sensit
achiev
microarray
immunoassay
use
roll
circl
amplif
techniqu
amplifi
oligonucleotid
primer
coval
link
detect
antibodi
combin
fluoresc
detect
amplifi
oligonucleotid
prove
possibl
detect
signal
individu
antigen
antibodi
complex
microarray
achiev
highli
sensit
assay
eg
detect
pgml
psa
pgml
ige
schweitzer
et
al
appli
simultan
measur
cytokin
glass
array
cytokin
could
detect
sensit
pgml
schweitzer
et
al
anoth
signal
amplif
techniqu
use
protein
microarray
tyramid
signal
amplif
also
known
catalyz
report
deposit
techniqu
use
hrp
label
catalyz
convers
fluoresc
tyramid
deriv
reactiv
intermedi
bind
adjac
tyrosin
residu
probe
varnum
et
al
regardless
type
label
one
disadvantag
labeldepend
detect
tendenc
label
modifi
bind
properti
molecul
attach
overcom
weak
number
labelfre
detect
techniqu
develop
recent
ad
advantag
allow
monitor
kinet
protein
microarraybind
reaction
real
time
exampl
techniqu
summar
tabl
spr
receiv
attent
matur
technolog
remaind
spri
carbon
nanowir
nanotub
cnt
interferometr
ellipsometr
techniqu
also
attract
signific
attent
offer
high
sensit
high
level
multiplex
capabl
still
present
research
level
mass
spectrometri
ms
techniqu
also
appli
microarray
immunoassay
part
biomark
discoveri
program
technolog
platform
develop
base
matrixassist
laserdesorpt
ioniz
timeofflight
malditof
ms
gavin
et
al
hortin
evansnguyen
et
al
surfaceenhanc
laserdesorptionion
timeofflight
selditof
ms
isaaq
et
al
et
al
method
protein
analyz
cocrystal
array
uv
absorb
compound
vapor
pulseduv
laser
beam
ioniz
protein
fragment
acceler
electr
field
identifi
veloc
character
differ
mass
charg
ratio
two
techniqu
differ
construct
sampl
target
analyz
design
method
provid
protein
pattern
sampl
use
extens
search
new
biomark
figur
antibodi
microarray
analysi
compar
pool
sera
sampl
pool
sera
react
respect
mix
togeth
appli
microarray
invers
label
sampl
appli
array
protein
elev
one
sourc
compar
either
fluoresc
green
red
protein
similar
level
sampl
appear
yellow
data
two
slide
averag
calcul
individu
protein
ratio
normal
array
median
calcul
absolut
level
individu
protein
note
red
spot
one
side
correspond
green
spot
dye
interchang
sampl
color
version
figur
may
view
wwwimmunoassayhandbookcom
reproduc
srivastava
et
al
permiss
elsevi
qualif
verif
candid
biomark
prove
challeng
though
ms
techniqu
emerg
offer
signific
potenti
acceler
process
multipl
reaction
monitoringm
mrmm
tripl
quadrupol
mass
spectromet
parent
peptid
ion
target
protein
select
masscharg
ratio
subject
collisioninduc
dissoci
monitor
select
fragment
use
standard
synthet
stabl
isotopelabel
version
signatur
proteotyp
peptid
sampl
stabl
isotop
dilut
sidmrmm
possibl
quantifi
test
provid
nearabsolut
structur
specif
keshishian
et
al
limit
sensit
method
aris
sampl
complex
serum
presenc
highabund
protein
overcom
incorpor
immunocaptur
process
siscapa
stabl
isotop
standard
captur
antipeptid
antibodi
method
anderson
et
al
effect
convent
immunometr
sandwich
immunoassay
replac
label
antibodi
ms
techniqu
achiev
low
nanogram
per
millilit
limit
quantit
cv
planar
array
spatial
posit
within
array
provid
identif
analyt
beadbas
microarray
reagent
coupl
bead
set
use
set
identifi
color
size
shape
code
type
bead
within
set
reagentspecif
microns
bead
pool
provid
multiplex
capabl
incub
sampl
use
protocol
analog
convent
immunometr
assay
detect
use
fluorescentlabel
antibodi
analyt
fluorescentlabel
streptavidin
biotintag
antibodi
wash
bead
suspens
process
form
flow
cytomet
identifi
bead
measur
fluoresc
bound
immunocomplex
beadbas
assay
robust
flexibl
easili
autom
use
standard
laboratori
fluidhandl
system
give
perform
compar
convent
elisa
kellar
iannon
popular
beadbas
platform
luminex
xmap
technolog
use
differ
colorcod
micron
diamet
bead
set
highthroughput
affin
rank
antibodi
phage
display
librari
wassaf
et
al
spri
allow
simultan
monitor
multipl
biomolecular
interact
entir
chip
surfac
illumin
reflect
light
captur
spot
ccd
camera
provid
realtim
kinet
data
monitor
bind
autoantibodi
sera
rheumatoid
arthriti
patient
lokat
et
al
nanohol
array
surfac
plasmon
side
metal
surfac
resonantli
coupl
subwavelength
hole
demonstr
simultan
monitor
bind
reaction
gst
gst
antibodi
ji
et
al
ellipsometri
measur
chang
polar
state
incid
light
depend
dielectr
properti
refract
index
film
protein
array
conjunct
microfluid
system
screen
antibodyantigen
interact
measur
five
marker
hepat
b
obliqu
incid
reflect
differ
oird
form
ellipsometri
harmon
modul
photocurr
measur
chang
thick
dielectr
respons
due
protein
bind
yield
detect
signal
suitabl
convent
glass
slide
applic
end
point
realtim
investig
dnadna
hybrid
antibodyantigen
captur
proteinsmal
moleculebind
reaction
spectral
reflect
imag
biosensor
optic
interfer
techniqu
wherebi
chang
optic
index
result
captur
biolog
materi
array
surfac
detect
use
optic
wave
interfer
demonstr
array
spot
four
protein
bind
antibodi
bsa
hsa
rabbit
igg
protein
g
et
al
dual
channel
biocd
simultan
detect
mass
fluoresc
spin
disc
format
measur
interferometri
fluoresc
demonstr
array
antirabbit
iggantimous
igg
spot
array
imag
reflectometri
depend
destruct
interfer
polar
light
reflect
silicon
substrat
measur
small
local
chang
optic
thick
thin
film
detect
human
protein
cellular
lysat
serum
mace
et
al
scan
kelvin
nanoprob
kelvin
probe
forc
microscop
detect
region
variat
surfac
potenti
across
substrat
interest
typic
gold
advantag
noncontact
techniqu
capabl
highspe
measur
highdens
array
demonstr
format
antigenantibodi
pair
high
sensit
reproduc
sinenski
belcher
atom
forc
microscopi
afm
highresolut
scan
probe
microscop
detect
vertic
horizont
deflect
cantilev
commonli
use
techniqu
famili
scan
probe
microscop
exampl
use
afm
labelfre
protein
pathogen
detect
huff
et
al
cnt
bind
target
protein
function
surfac
lead
detect
chang
electr
conduct
devic
use
singl
wall
cnt
labelfre
immunosensor
detect
psa
okuno
et
al
microcantilev
siliconbas
goldcoat
surfac
suspend
horizont
solid
support
deflect
due
biomolecular
interact
detect
either
optic
measur
chang
reflect
angl
electr
use
metal
oxid
semiconductor
fet
antigenantibodybind
assay
yue
et
al
adapt
ray
et
al
copyright
wileyvch
verlag
gmbh
co
kgaa
reproduc
permiss
instrument
measur
fluoresc
two
wavelength
firstli
identifi
bead
set
individu
bead
secondli
quantifi
bound
immunocomplex
open
architectur
system
allow
research
set
multiplex
assay
select
wide
rang
commerci
avail
kit
luminex
one
partner
organ
wwwluminexcorp
com
addit
updat
system
luminex
offer
expand
differ
bead
set
flexmap
system
compact
magpix
system
base
colorcod
magnet
microspher
fluoresc
imag
detect
use
led
ccd
camera
replac
laser
photomultipli
flow
cytometri
system
see
microspherebas
multiplex
immunoassay
develop
applic
use
luminex
xmap
technolog
beadbas
system
includ
cytometr
bead
array
cba
bd
bioscienc
wwwbdbiosciencescom
use
differ
spectral
identifi
bead
set
multiplex
immunoassay
kit
ebiosci
bead
set
distinguish
combin
size
dye
intens
wwwebiosciencecom
enzo
life
scienc
similar
immunoassay
kit
wwwenzolifesciencescom
altern
configur
bioarray
solut
system
immucor
use
spectral
distinguish
bead
type
run
test
bead
mixtur
immobil
monolay
silicon
chip
remov
unbound
detect
conjug
end
assay
array
read
dedic
imag
system
wwwimmucorcombioarray
illumina
technolog
use
cylindr
glass
microbead
length
diamet
holograph
code
solid
phase
multiplex
system
bead
collect
groov
plate
read
code
identifi
bead
type
fluoresc
intens
bound
immunocomplex
wwwilluminacom
although
origin
develop
dna
analysi
illumina
provid
carboxylderivat
glass
bead
set
user
develop
immunoassay
rel
merit
bead
planar
microarray
debat
within
research
commun
advoc
planar
varieti
claim
greater
level
multiplex
ten
thousand
test
singl
array
eas
handl
low
nsb
use
commonli
avail
laboratori
equip
possibl
use
differ
label
labelfre
detect
bead
microarray
limit
multiplex
possibl
practic
limit
region
analyt
within
test
mix
test
specif
becom
problem
advantag
capabl
independ
qualiti
control
bead
set
thu
suit
verif
valid
requir
test
use
clinic
diagnosi
follow
fda
clearanc
sinc
oper
version
highdens
protein
antibodi
microarray
first
brought
use
macbeath
schreiber
becom
robust
stabl
platform
protein
express
profil
biomark
identif
diseas
profil
antibodi
character
clinic
diagnosi
becom
essenti
tool
proteom
research
protein
microarray
enabl
parallel
quantif
hundr
protein
small
sampl
volum
provid
research
abil
compar
concentr
pattern
patient
particular
diseas
control
patient
major
diseas
specif
proteom
studi
perform
sampl
patient
cancer
exampl
activ
area
includ
studi
lung
cancer
gao
et
al
use
array
demonstr
discrimin
lung
cancer
patient
control
breast
cancer
sebastiani
et
al
use
protein
carcinoma
sampl
evalu
surviv
correl
breast
cancer
sauer
et
al
use
protein
identifi
group
five
could
use
distinguish
specif
subgroup
patient
thyroid
cancer
linkov
et
al
plasma
pattern
cytokin
chemokin
growth
factor
use
identifi
five
could
use
discrimin
malign
benign
thyroid
condit
bladder
cancer
sanchezcarbayo
et
al
use
antibodi
array
differ
antibodi
discrimin
cancer
patient
control
classif
rate
mani
studi
perform
patient
ovarian
cancer
includ
studi
phosphospecif
antibodi
wulfkuhl
et
al
assay
screen
patient
ovarian
cancer
show
sensit
specif
within
popul
newli
diagnos
ovarian
cancer
patient
healthi
subject
visintin
et
al
studi
hudson
et
al
use
protein
microarray
identifi
autoantibodi
set
capabl
recogn
antigen
sera
patient
ovarian
cancer
select
two
antigen
combin
perform
better
alon
identifi
ovarian
cancer
prostat
cancer
also
receiv
consider
attent
mani
microarray
studi
perform
includ
use
reversephas
protein
array
follow
diseas
progress
paweletz
et
al
microarray
antibodi
use
examin
prostat
cancer
sera
control
identifi
five
protein
significantli
differ
level
two
cohort
miller
et
al
studi
shafer
et
al
indic
could
differenti
benign
malign
diseasedespit
correl
psa
exampl
clinic
applic
includ
studi
serum
sampl
sever
acut
respiratori
syndrom
outbreak
use
coronaviru
protein
microarray
protein
demonstr
protein
microarray
use
largescal
identif
virusspecif
antibodi
sera
zhu
et
al
work
bozza
et
al
evalu
cytokin
sepsisspecif
biomark
identifi
correl
organ
dysfunct
mani
commerci
microarray
product
avail
research
use
includ
protein
antibodi
array
eg
cytokin
chemokin
tumor
marker
growth
factor
tabl
list
exampl
commerci
planar
microarray
system
avail
research
use
beadbas
system
domin
luminex
xmap
magpix
system
research
use
extens
menu
test
avail
luminex
partner
includ
millipor
r
system
biorad
invitrogen
innogenet
inver
medic
rulesbas
medicin
affymetrix
zeu
scientif
cover
panel
autoimmun
diseas
cardiac
marker
inflammatori
diseas
apoptosi
cellular
signal
cytokin
chemokin
growth
factor
endocrin
metabol
marker
neurobiolog
supplier
beadbas
system
commerci
avail
research
use
product
adhes
molecul
cytokin
chemokin
bd
bioscienc
cba
system
cytokin
chemokin
adhes
molecul
cardiovascular
marker
obes
marker
ebiosci
flowcytomix
system
cytokin
custom
design
panel
enzo
life
scienc
system
fdaclear
european
cemark
multiplex
array
product
limit
thu
far
restrict
panel
test
analyt
alreadi
clearanc
individu
test
luminex
multiplex
system
lend
applic
clinic
diagnosi
requir
result
rel
small
number
test
list
current
avail
test
clinic
use
reflect
domin
test
autoimmun
infecti
diseas
tabl
capabl
simultan
analysi
hundr
thousand
protein
interact
offer
major
advanc
biomark
discoveri
program
despit
potenti
yield
disappoint
rate
introduct
new
protein
analyt
routin
clinic
use
averag
per
year
last
year
anderson
research
offer
explan
includ
lack
effect
technolog
platform
verif
larg
sampl
set
limit
access
clinic
sampl
absenc
defin
coher
biomark
develop
pipelin
altern
view
whiteley
suggest
lack
new
product
avail
clinic
laboratori
reflect
industri
risk
avoid
academ
focu
discoveri
lack
understand
research
high
standard
robust
reproduc
requir
satisfi
regulatori
agenc
latter
point
accept
proteom
research
commun
effort
close
gap
candid
biomark
discoveri
clinic
util
sever
initi
tri
remov
uncertainti
among
translat
research
specif
analyt
measur
criteria
need
valid
proteinbas
multiplex
assay
context
us
nation
cancer
institut
clinic
proteom
technolog
cancer
initi
ncicptc
proteomicscancergov
propos
preclin
verif
stage
biomark
pipelin
partner
clinic
laboratori
organ
develop
common
standard
work
close
fda
educ
proteom
commun
regard
evalu
requir
part
process
member
ncicptc
prepar
two
mock
presubmiss
protein
multiplex
assay
descript
offic
vitro
diagnost
devic
evalu
safeti
us
fda
feedback
regnier
et
al
guidanc
given
includ
need
give
adequ
attent
understand
potenti
failur
mode
affect
robust
reliabl
take
care
select
appropri
intend
use
popul
rel
collect
test
specimen
valid
avail
multipl
test
result
singl
sampl
present
new
challeng
term
qualiti
control
whether
result
report
individu
fed
algorithm
produc
singl
result
multivari
index
assay
ivdmia
array
may
provid
result
hundr
thousand
analyt
convent
laboratori
protocol
daili
monitor
high
mid
low
analyt
level
control
perform
becom
impract
particularli
planar
array
master
et
al
greater
degre
multiplex
greater
problem
event
one
analyt
give
respons
outsid
expect
rang
consider
given
result
analyt
handl
also
issu
contend
regard
releas
unrequest
result
commerci
ethic
legal
implicationsal
need
address
test
commerci
scale
problem
much
limit
beadbas
microarray
particularli
multiplex
limit
rel
small
number
analytesh
current
menu
fdaclear
beadbas
test
domin
panel
test
autoimmun
infecti
diseas
larger
scale
multiplex
util
veripsych
test
rule
base
medicin
measur
panel
protein
marker
aid
schizophrenia
diagnosi
present
limit
test
classifi
laboratori
develop
test
rather
wider
usag
permit
fda
clearanc
new
biomark
discoveri
proteom
technolog
like
play
role
singl
technolog
provid
high
level
multiplex
high
sensit
specif
level
robust
reliabl
compar
today
clinic
laboratori
analyz
likelihood
combin
immunoaffinitymass
spectrometr
antibodi
microarray
techniqu
provid
relev
tool
within
structur
biomark
develop
program
term
clinic
usag
exist
opportun
multiplex
protein
panel
interpret
algorithm
provid
patient
specif
baselin
monitor
medic
condit
truli
person
rather
comparison
populationbas
refer
interv
approach
may
allow
detect
smaller
chang
pattern
protein
sampl
thu
earlier
indic
diseaserel
chang
consid
possibl
microarray
compet
exist
laboratori
analyz
note
exist
system
easili
increas
throughput
request
test
sampl
run
sequenc
diagnost
compani
unlik
invest
heavili
develop
new
multiplex
system
benefit
gain
multiplex
expect
ivdmia
sampl
volum
limit
chapter
illustr
consider
research
effort
gone
address
object
miniatur
immunoassay
success
achiev
particularli
innov
analyt
scienc
appli
solut
wide
rang
challeng
howev
ultim
success
true
measur
innov
judg
level
adopt
applic
sector
technolog
intend
ultim
success
depend
clear
definit
problem
address
well
capabl
endus
organ
adopt
solut
present
time
adopt
loc
concept
greater
research
set
set
clinic
diagnost
highlight
forego
discuss
may
arena
applic
loc
poc
test
offer
potenti
benefit
eg
environment
food
materi
authent
test
speed
simplic
mobil
desir
attribut
financi
environment
issu
equal
applic
modal
test
doubt
market
greatest
volum
applic
found
howev
know
experi
poc
test
see
pointofcar
test
adopt
slow
furthermor
barrier
adopt
new
technolog
health
care
acknowledg
one
key
barrier
poor
understand
unmet
need
might
address
new
technolog
might
selfevid
analyt
devic
address
unmet
need
recogn
clinic
diagnost
signific
overrequest
test
probabl
encourag
predomin
feeforservic
busi
model
furthermor
lesson
learn
evolut
central
laboratori
analyt
technolog
earli
approach
scope
develop
multichannel
analyz
becam
evid
wide
adopt
technolog
patient
test
analyt
biomark
necessarili
relev
condit
rais
two
issu
first
whether
patient
insur
pay
test
requir
second
proport
abnorm
result
report
relev
clinic
condit
investig
consequ
experi
develop
discretionari
analyz
greater
emphasi
relev
biomark
group
biomark
consequ
scope
major
attribut
loc
concept
present
greater
challeng
formul
right
group
biomark
demonstr
clinic
util
ethic
issu
surround
gener
result
request
refer
earlier
discuss
also
consid
well
grow
demand
evid
clinic
util
part
patient
demand
improv
qualiti
health
care
servic
thu
proof
principl
loc
diagnost
achiev
routin
applic
lag
behind
may
someth
els
learn
poc
test
adopt
slow
failur
make
good
busi
case
inabl
custom
organ
make
chang
clinic
practic
associ
introduct
disrupt
technolog
sever
scenario
test
might
use
involv
one
test
consequ
singl
analyt
poc
test
begin
appear
time
consum
poc
small
number
test
perform
sequenti
one
patient
howev
loc
solut
might
right
answer
challeng
lie
choic
test
run
parallel
mani
test
appear
number
clinic
relev
menu
furthermor
diseaserel
menu
alway
limit
analyt
measur
use
immunoassay
principl
therefor
rais
two
issu
first
loc
devic
embrac
one
analyt
technolog
second
real
strength
loc
devic
choic
lie
flexibl
manufactur
abil
produc
portfolio
multianalyt
dispos
devic
portfolio
custom
depend
doubt
microscal
analyt
devic
huge
potenti
applic
wider
rang
set
furthermor
mani
custom
need
particularli
rang
analyt
interest
proven
development
set
translat
howev
set
miniatur
devic
best
suiteda
mobil
set
immediaci
respons
requir
technic
expertiseremain
challeng
relat
demonstr
robust
devic
testanalyt
configur
meet
individu
custom
need
